• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丹麦结直肠癌筛查项目中的结肠镜检查时间、癌症概率及癌前病变

Time to colonoscopy, cancer probability, and precursor lesions in the Danish colorectal cancer screening program.

作者信息

Kaalby Lasse, Rasmussen Morten, Zimmermann-Nielsen Erik, Buijs Magdalena Maria, Baatrup Gunnar

机构信息

Department of Surgery, Odense University Hospital, Odense, Denmark.

Department of Clinical Science, University of Southern Denmark, Odense, Denmark.

出版信息

Clin Epidemiol. 2019 Jul 30;11:659-667. doi: 10.2147/CLEP.S206873. eCollection 2019.

DOI:10.2147/CLEP.S206873
PMID:31440102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6679696/
Abstract

PURPOSE

The aim of this study was to investigate the effect of response time from the Fecal Immunochemical Test (FIT) based screening invitation to the conclusive screening Optical Colonoscopy (OC) on the risk of detecting colorectal cancer (CRC), advanced stage disease and precursor lesions.

PATIENTS AND METHODS

We used a cross-sectional study design and included all 62,554 screening participants registered in the Danish Colorectal Cancer Screening Database who tested FIT-positive between March 2014 and December 2016. The main exposure was response time, measured as the time from initial invitation to the conclusive OC. Our main outcomes were the probability of being diagnosed with CRC, advanced stage disease or precursor lesions.

RESULTS

Of the 62,554 FIT-positive participants, 53,171 (85%) received an OC and were eligible for analysis (median age 63.7 years, 56% men). In this group, 3,639 cancers were registered, 2,890 of which were registered with a defined stage of disease (79%), and 1,042 (36%) of these were advanced stage (UICC III & IV). In addition, 17,732 high-risk and 10,605 low-risk adenomas were identified. Compared to participants receiving the conclusive examination within 30 days, those receiving the examination more than 90 days after initial invitation were 3.49 times more likely to be diagnosed with any CRC (OR 3.49 [95% CI, 3.13-3.89]) and 2.10 times more likely to have advanced stage disease (OR 2.10 [95% CI, 1.73-2.56]). Those waiting for the longest were also more likely to have one or more high-risk adenomas (OR 1.59 [95% CI, 1.50-1.68]).

CONCLUSION

Increased screening response time was associated with a higher probability of detecting high-risk adenomas, any stage CRC and advanced stage cancer. More research is needed to explain what causes these associations.

摘要

目的

本研究旨在调查从基于粪便免疫化学检测(FIT)的筛查邀请到最终筛查光学结肠镜检查(OC)的响应时间对检测结直肠癌(CRC)、晚期疾病和前驱病变风险的影响。

患者与方法

我们采用横断面研究设计,纳入了丹麦结直肠癌筛查数据库中2014年3月至2016年12月期间FIT检测呈阳性的所有62554名筛查参与者。主要暴露因素为响应时间,定义为从初次邀请到最终OC检查的时间。我们的主要结局是被诊断为CRC、晚期疾病或前驱病变的概率。

结果

在62554名FIT检测呈阳性的参与者中,53171名(85%)接受了OC检查并符合分析条件(中位年龄63.7岁,56%为男性)。在该组中,登记了3639例癌症,其中2890例有明确的疾病分期(79%),其中1042例(36%)为晚期(国际抗癌联盟III期和IV期)。此外,还发现了17732例高危腺瘤和10605例低危腺瘤。与在30天内接受最终检查的参与者相比,在初次邀请后90天以上接受检查的参与者被诊断为任何CRC的可能性高3.49倍(比值比3.49 [95%可信区间,3.13 - 3.89]),患晚期疾病的可能性高2.10倍(比值比2.10 [95%可信区间,1.73 - 2.56])。等待时间最长的参与者也更有可能有一个或多个高危腺瘤(比值比1.59 [95%可信区间,1.50 - 1.68])。

结论

筛查响应时间延长与检测高危腺瘤、任何阶段CRC和晚期癌症的可能性增加相关。需要更多研究来解释这些关联的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4746/6679696/2fd91f4f6497/CLEP-11-659-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4746/6679696/2fd91f4f6497/CLEP-11-659-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4746/6679696/2fd91f4f6497/CLEP-11-659-g0001.jpg

相似文献

1
Time to colonoscopy, cancer probability, and precursor lesions in the Danish colorectal cancer screening program.丹麦结直肠癌筛查项目中的结肠镜检查时间、癌症概率及癌前病变
Clin Epidemiol. 2019 Jul 30;11:659-667. doi: 10.2147/CLEP.S206873. eCollection 2019.
2
Subsequent participation in organized FIT based screening following screen-derived colonoscopy .在因筛查进行结肠镜检查后,后续参与基于粪便免疫化学试验(FIT)的有组织筛查。
Prev Med Rep. 2023 Feb 3;32:102125. doi: 10.1016/j.pmedr.2023.102125. eCollection 2023 Apr.
3
4
5
Fecal MicroRNA-Based Algorithm Increases Effectiveness of Fecal Immunochemical Test-Based Screening for Colorectal Cancer.粪便 microRNA 算法提高粪便免疫化学试验筛查结直肠癌的效果。
Clin Gastroenterol Hepatol. 2021 Feb;19(2):323-330.e1. doi: 10.1016/j.cgh.2020.02.043. Epub 2020 Feb 28.
6
Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.用于结直肠癌筛查的粪便潜血试验:一项基于证据的分析。
Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1.
7
Colonoscopy later than 270 days in a fecal immunochemical test-based population screening program is associated with higher prevalence of colorectal cancer.在基于粪便免疫化学试验的人群筛查计划中,结肠镜检查晚于 270 天与结直肠癌的更高患病率相关。
Endoscopy. 2020 Oct;52(10):871-876. doi: 10.1055/a-1159-0644. Epub 2020 Apr 30.
8
Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis.粪便检测结果呈阳性后至结肠镜检查的时间与结直肠癌风险及诊断时癌症分期之间的关联。
JAMA. 2017 Apr 25;317(16):1631-1641. doi: 10.1001/jama.2017.3634.
9
Time to Colonoscopy and Risk of Colorectal Cancer in Patients With Positive Results From Fecal Immunochemical Tests.粪便免疫化学检测阳性患者行结肠镜检查的时间与结直肠癌风险。
Clin Gastroenterol Hepatol. 2019 Jun;17(7):1332-1340.e3. doi: 10.1016/j.cgh.2018.10.041. Epub 2018 Nov 1.
10

引用本文的文献

1
Adherence to Follow-Up Colonoscopy After a Positive Stool-Based Test in Patients Aged 45-49 Years: Real-World Differences Between Multitarget Stool DNA Testing and Fecal Immunochemical or Fecal Occult Blood Testing.45-49岁粪便检测呈阳性患者后续结肠镜检查的依从性:多靶点粪便DNA检测与粪便免疫化学或粪便潜血检测在现实世界中的差异
Gastro Hep Adv. 2025 May 16;4(9):100706. doi: 10.1016/j.gastha.2025.100706. eCollection 2025.
2
Performance of Faecal Immunochemical Testing for Colorectal Cancer Screening at Varying Positivity Thresholds.不同阳性阈值下粪便免疫化学检测用于结直肠癌筛查的性能
Aliment Pharmacol Ther. 2025 Jan;61(1):122-131. doi: 10.1111/apt.18314. Epub 2024 Oct 7.
3

本文引用的文献

1
Determinants of non-participation in colon examination following positive stool sample in colorectal cancer screening.结直肠癌筛查中阳性粪便样本后不参与结肠镜检查的决定因素。
Eur J Public Health. 2019 Dec 1;29(6):1118-1124. doi: 10.1093/eurpub/ckz072.
2
Selecting a Cut-off for Colorectal Cancer Screening With a Fecal Immunochemical Test.选择粪便免疫化学检测用于结直肠癌筛查的临界值。
Clin Transl Gastroenterol. 2017 Aug 3;8(8):e111. doi: 10.1038/ctg.2017.37.
3
Sociodemographic predictors of participation in colorectal cancer screening.
Evaluation of the "Burgenland PREvention trial of colorectal cancer Disease with ImmunologiCal Testing" (B-PREDICT)-a population-based colorectal cancer screening program.
评估“布尔根兰预防性结直肠癌免疫试验”(B-PREDICT)-一项基于人群的结直肠癌筛查计划。
BMC Gastroenterol. 2024 Apr 30;24(1):149. doi: 10.1186/s12876-024-03242-7.
4
Development of a Follow-Up Measure to Ensure Complete Screening for Colorectal Cancer.制定后续措施以确保全面进行结直肠癌筛查
JAMA Netw Open. 2024 Mar 4;7(3):e242693. doi: 10.1001/jamanetworkopen.2024.2693.
5
Association between time to colonoscopy after positive fecal testing and colorectal cancer outcomes in Alberta, Canada.加拿大艾伯塔省粪便检测阳性后行结肠镜检查的时间与结直肠癌结局的关系。
J Med Screen. 2024 Dec;31(4):232-238. doi: 10.1177/09691413241239023. Epub 2024 Mar 15.
6
Postponing colonoscopy for 6 months in high-risk population increases colorectal cancer detection in China.在中国高危人群中,将结肠镜检查推迟 6 个月会增加结直肠癌的检出率。
Cancer Med. 2023 May;12(10):11816-11827. doi: 10.1002/cam4.5850. Epub 2023 Mar 23.
7
The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic.荷兰在 COVID-19 大流行期间基于全国性 FIT 筛查的结直肠癌筛查项目。
Prev Med. 2021 Oct;151:106643. doi: 10.1016/j.ypmed.2021.106643. Epub 2021 Jun 30.
8
Time to Colonoscopy After Abnormal Stool-Based Screening and Risk for Colorectal Cancer Incidence and Mortality.粪便潜血检查异常后行结肠镜检查的时间与结直肠癌发病率和死亡率的关系。
Gastroenterology. 2021 May;160(6):1997-2005.e3. doi: 10.1053/j.gastro.2021.01.219. Epub 2021 Feb 2.
9
Impact of SARS-CoV-2 Pandemic on Colorectal Cancer Screening Delay: Effect on Stage Shift and Increased Mortality.SARS-CoV-2 大流行对结直肠癌筛查延迟的影响:对分期转移和死亡率增加的影响。
Clin Gastroenterol Hepatol. 2021 Jul;19(7):1410-1417.e9. doi: 10.1016/j.cgh.2020.09.008. Epub 2020 Sep 6.
10
Preferences for different diagnostic modalities to follow up abnormal colorectal cancer screening results: a hypothetical vignette study.不同诊断方式在随访结直肠癌筛查异常结果中的偏好:一项假设性病例研究。
BMJ Open. 2020 Jul 26;10(7):e035264. doi: 10.1136/bmjopen-2019-035264.
参与结直肠癌筛查的社会人口学预测因素。
Int J Colorectal Dis. 2017 Aug;32(8):1117-1124. doi: 10.1007/s00384-017-2832-6. Epub 2017 May 13.
4
Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis.粪便检测结果呈阳性后至结肠镜检查的时间与结直肠癌风险及诊断时癌症分期之间的关联。
JAMA. 2017 Apr 25;317(16):1631-1641. doi: 10.1001/jama.2017.3634.
5
Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels.荷兰结直肠癌筛查计划第一年中实时监测结果以及通过调整粪便免疫化学检测截断值进行优化
Gastroenterology. 2017 Mar;152(4):767-775.e2. doi: 10.1053/j.gastro.2016.11.022. Epub 2016 Nov 24.
6
Screening for Colorectal Cancer: A Systematic Review and Meta-Analysis.结直肠癌筛查:一项系统评价与荟萃分析
Clin Colorectal Cancer. 2016 Dec;15(4):298-313. doi: 10.1016/j.clcc.2016.03.003. Epub 2016 Mar 31.
7
Improved survival of colorectal cancer in Denmark during 2001-2012 - The efforts of several national initiatives.2001年至2012年丹麦结直肠癌患者生存率提高——多项国家举措的成效
Acta Oncol. 2016 Jun;55 Suppl 2:10-23. doi: 10.3109/0284186X.2015.1131331. Epub 2016 Feb 9.
8
Colorectal cancer screening: tests, strategies, and perspectives.结直肠癌筛查:检测、策略和观点。
Front Public Health. 2014 Oct 27;2:210. doi: 10.3389/fpubh.2014.00210. eCollection 2014.
9
Factors associated with incomplete colonoscopy at a Japanese academic hospital.日本一家学术医院结肠镜检查不完全的相关因素。
World J Gastroenterol. 2014 Jun 14;20(22):6961-7. doi: 10.3748/wjg.v20.i22.6961.
10
Multitarget stool DNA testing for colorectal-cancer screening.多靶点粪便 DNA 检测用于结直肠癌筛查。
N Engl J Med. 2014 Apr 3;370(14):1287-97. doi: 10.1056/NEJMoa1311194. Epub 2014 Mar 19.